There are about 16 Million Americans with rosacea, and a whopping 77% of them are wearing makeup to cover up their redness. I fully admit that I’m one of them! Depending on the day, I can wear BB Cream, redness corrector, concealer, foundation, powder… the list of makeup I use to cover up my redness is pretty long.
Mirvaso® (brimonidine) topical gel, 0.33%*, a prescription drug that treats the persistent facial redness of rosacea, has created a website with information about rosacea. You’ll find startling statistics about how many people suffer from rosacea, how many of us are covering it up and even some great skincare tips from New York City dermatologist Dr. Doris Day.
While you’re learning more about rosacea, don’t forget to enter for a chance to win a trip to the Emmy’s!
Mirvaso is a prescription drug and you’ll need to see your doctor (remember, I’m a doctor, but I’m not your doctor!) to discuss whether it is a good option for you.
Important Safety Information Indication: Mirvaso® (brimonidine) topical gel, 0.33%* is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
*Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.